It doesn’t take long to find them: Reddit threads, TikTok videos, and message boards offering step-by-step guides on how to get prescriptions for Adderall, Xanax, Ambien—you name it. In this underground world of psychopharm advice, individuals swap tips on faking symptoms, gaming telehealth platforms, and outmaneuvering cautious clinicians. It’s a digital playbook for accessing controlled substances, often without a clinically sound indication. But here’s the catch. Not all who follow these scripts are manipulating the system. Some are simply desperate for relief and navigating a fragmented healthcare system with few good options.

Clinicians rarely spend time in these digital spaces, but they should—because these narratives influence how patients present in real life. The COVID-19 pandemic brought a boom in telehealth services, but with it came platforms focused on convenience and profit over clinical rigor (Reeves JJ and Ayers JW, J Med Internet Res 2021;23(2):e24785). So, what are the tactics patients are learning and using?

Case vignette
You sit across from a 24-year-old patient who presents over telehealth, reporting persistent anxiety. The patient notes that SSRIs “just don’t work” and therapy hasn’t helped. They press for something fast, emphasizing the severity of their panic. As the visit progresses, you recognize the familiar cadence of TikTok scripts and wonder: Is this a cry for help, or a rehearsed performance drawn from online forums?

The online playbook: Benzodiazepines
On Reddit and TikTok, one of the most common tips is to never ask for a medication by name. Instead, users are encouraged to describe vague symptoms like “intense anxiety” or “panic attacks” and let the provider connect the dots. A frustrated Redditor on r/mentalhealth asked, “How long do I have to keep telling my doctor ‘This doesn’t work’ until they finally give in?”—a tactic that displays persistent dissatisfaction with safer alternatives in an attempt to push for benzodiazepines. Another user described jumping from provider to provider until they found someone willing to prescribe without deeper evaluation or a long-term treatment plan.

TikTok is just as explicit. Creators offer scripted phrasing: “I’ve tried SSRIs and therapy, but I still have panic attacks. I need something fast.” This formula—vague complaints, failure of alternatives, and urgency—nudges the clinician toward prescribing without formally asking for the drug. If you’ve heard this, you’re not alone. It’s a common formula in these communities.

Expanding the definition of ADHD
The ADHD diagnosis is also being stretched beyond its clinical definition. On TikTok and Reddit, self-diagnosis has exploded, with individuals claiming ADHD based on statements like, “I can’t multitask,” “I lose focus easily,” or “I get songs stuck in my head.” These overly broad symptoms blur the line between true attentional pathology and common life challenges, pressuring clinicians to diagnose based on social media–driven expectations rather than structured evaluations (Schiros A et al, Eur Child Adolesc Psychiatry; published online June 5, 2025).

Individuals on Reddit frequently share advice on how to build a convincing narrative. Tips include:

• Reciting DSM-5 criteria verbatim
• Claiming an established diagnosis to bypass further evaluation
• Requesting an ADHD assessment to initiate the diagnosis process
• Reporting failed non-stimulant trials (eg, atomoxetine) to guide the clinician toward stimulant treatment

One viral TikTok post even linked an ADHD checklist directly to a telehealth ad offering a 15-minute screening followed by a same-day prescription.

What can clinicians do?
Awareness of these tactics is critical, but judgment alone isn’t enough. Here are some practical strategies to reduce inappropriate prescribing while still delivering compassionate care:

Use structured tools
Employ validated assessments such as:

• DIVA-5 (Diagnostic Interview for ADHD in Adults, $12 one-time fee at www.divacenter.eu)
• Conners’ Adult ADHD Rating Scales (CAARS), Adult ADHD Self-Report Scale (ASRS), and Brown Attention Scales

But remember, these are only tools. They should be supplemented with collateral history, academic or occupational records, and prior treatment documentation when possible (Ramos-Quiroga JA et al, J Atten Disord 2019;23(10)).

Review substance use and prescribing history
A thorough review of current and past substance use is essential, including stimulants, benzodiazepines, and opioids. Check your state’s prescription drug monitoring program (PDMP) before initiating any controlled substance.

Get collateral input
Input from relatives, teachers, and school report cards inform the ADHD diagnosis.

Set expectations early
Establish treatment agreements that define:

• Refill policies
• Protocols for lost prescriptions
• Functional goals (not just symptom relief)

Offer safer first-line options

• For ADHD: Start with non-stimulants (eg, bupropion, atomoxetine, guanfacine), especially in ambiguous cases.
• For anxiety: Favor SSRIs/SNRIs, buspirone, hydroxyzine, or therapy over benzodiazepines, particularly for first-time presentations.

Require regular follow-up
Monthly visits can assess symptom control, functional improvement, and medication adherence. Early contact helps spot misuse before it becomes problematic.

Normalize saying no—with empathy
Declining to prescribe doesn’t have to be adversarial. Frame it around safety and clinical appropriateness: “This medication can be helpful for some people, but based on what I’m seeing today, I think there may be better—and safer—options for you.”

CARLAT VERDICT
Clinicians can’t afford to be naïve. Today, patients arrive armed with scripts, not just symptoms. TikTok and Reddit are rewriting how psychiatry looks in the exam room. Your best defense isn’t cynicism. It is structure, curiosity, and firm but compassionate boundaries. If you don’t adapt to this digital playbook, you risk being played.